Abstract:Previous study has shown that administration of melatonin into the anterior cingulate cortex contralateral to peripheral nerve injury prevented exacerbation of mechanical allodynia with a concurrent improvement of depression-like behavior in Wistar–Kyoto (WKY) rats, a genetic variation of Wistar rats. In the present study, we examined the effect of the individual versus combined treatment of melatonin and/or dextromethorphan (DM), a clinically available N-methyl-d-aspartate (NMDA) receptor antagonist, on pain behaviors in WKY rats with chronic constriction sciatic nerve injury (CCI). Pain behaviors (thermal hyperalgesia and mechanical allodynia) were established at one week after CCI. WKY rats were then treated intraperitoneally with various doses of melatonin, DM or their combination once daily for the following week. At the end of this one-week treatment, behavioral tests were repeated in these same rats. While DM alone was effective in reducing thermal hyperalgesia at three tested doses (15, 30 or 60 mg/kg), it reduced mechanical allodynia only at high doses (30 or 60 mg/kg). By comparison, administration of melatonin alone was effective in reducing thermal hyperalgesia only at the highest dose (120 mg/kg, but not 30 or 60 mg/kg) tested in this experiment. Melatonin alone failed to reverse allodynia at all three tested doses (30, 60 and 120 mg/kg). However, the combined intraperitoneal administration of melatonin (30 mg/kg) and DM (15 mg/kg) effectively reversed both thermal hyperalgesia and mechanical allodynia although each individual dose alone did not reduce pain behaviors. These results suggest that a combination of melatonin with a clinically available NMDA receptor antagonist might be more effective than either drug alone for the treatment of neuropathic pain.

[Effect of Melatonin on Release of Beta-Endorphin, Norepinephrine and 5-Hydroxytryptamine in Rat Brain].

Melatonin Influences the Release of Endogenous Opioid Peptides in Rat Periaqueductal Gray

Melatonin Attenuates the Intensity of Beta-Endorphin Immunoreactivity in the Arcuate Nucleus of Rat Hypothalamus.

Effect of Melatonin on the Level of Dynorphin in Rat Brain

The Analgesic Effects of Peripheral and Central Administration of Melatonin in Rats.

Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis.

Exogenous Melatonin in the Treatment of Pain: a Systematic Review and Meta-Analysis

Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies

Melatonin Suppresses Neuropathic Pain Via MT2-Dependent and -Independent Pathways in Dorsal Root Ganglia Neurons of Mice.

Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions

Melatonin Attenuates Inflammatory Response‐induced Brain Edema in Early Brain Injury Following a Subarachnoid Hemorrhage: a Possible Role for the Regulation of Pro‐inflammatory Cytokines

A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats.

Melatonin Enhances Antinociceptive Effects of Δ-, but Not Μ-Opioid Agonist in Mice

Pain Control by Melatonin: Physiological and Pharmacological Effects

Changes of Cerebral Β-Endorphin in Rats Treated with Combination Therapy of Melatonin and Electroacupuncture

Effects of Melatonin on Orphanin FQ/nociceptin-induced Hyperalgesia in Mice

Does exogenous melatonin influence the metabolism of free radicals and pain sensation in the rat?

Analgesic Effects of Melatonin on Post-Herpetic Neuralgia.

Melatonin in Pain Modulation: Analgesic or Proalgesic?

Melatonin Induces Analgesic Effects through MT2 Receptor-Mediated Neuroimmune Modulation in the Mice Anterior Cingulate Cortex

Selective Mt2 Melatonin Receptor Antagonist Blocks Melatonin-Induced Antinociception in Rats